Utility of Urinary Extracellular Vesicles for Colorectal Cancer: Comparison of DNA Quality and MRD Detection
Cancer Science · 2026
DOI: 10.1111/cas.70368 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer Science, 2026. Verfasst von Shintaro Kanaka und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Nippon Medical School, Tokyo, Japan. Hauptthemen laut MEDLINE: Extracellular Vesicles, Colorectal Neoplasms, Neoplasm, Residual, Circulating Tumor DNA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This study evaluated the feasibility of urinary extracellular vesicles (EVs) as a liquid biopsy source for colorectal cancer (CRC) using two predefined cohorts: 97 patients for analytical validation and 63 patients for postoperative survival analysis. We compared urinary EVs, urinary cell‐free tumor DNA (ctDNA), plasma EVs, and plasma ctDNA across multiple molecular dimensions, and assessed the utility of urinary EV‐DNA for minimal residual disease (MRD) detection. Urinary EVs exhibited larger particle size (median 175.6 nm) and markedly higher purity, demonstrated by a substantially broader proteomic profile (4674 vs. 476 proteins) and significantly higher expression of EV‐specific markers (CD63, CD81, CD9). DNA extracted from urinary EVs showed the highest concentration and best preservation of nucleic acid integrity, with the greatest Long/Short fragment ratio, outperforming all plasma‐derived samples. Mutation detection sensitivity was comparable across sample types but was highest in plasma ctDNA (39.2%) and urinary EV‐DNA (34.0%), exceeding urinary ctDNA (21.6%). In the survival cohort, MRD positivity—defined as detectable RAS/BRAF mutations in urinary EV‐DNA 1 month after curative surgery—was strongly associated with inferior outcomes (HR for recurrence 5.25, 95% CI 1.74–15.80), and overall survival was significantly worse in MRD‐positive patients. These findings indicate that urinary EVs provide highly pure vesicles with superior DNA quality, making them a robust and completely non‐invasive source for molecular profiling. Urinary EV‐DNA–based MRD assessment shows significant prognostic value and may serve as a practical tool for postoperative monitoring and risk stratification in colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Nippon Medical School, Tokyo, Japan.
- H.U. Group Research Institute, G. K., Tokyo, Japan.
ORCID-Profile: Shintaro Kanaka, Takeshi Yamada, Seiichi Shinji, Kohki Takeda, Toshimitsu Miyasaka
Zitieren
APA
Kanaka, S., Yamada, T., Asai, F., Shimizu, Y., Uehara, K., Matsuda, A., Shinji, S., Yokoyama, Y., Takahashi, G., Iwai, T., Takeda, K., Kuriyama, S., Miyasaka, T., Hayashi, K., & Yoshida, H. (2026). Utility of Urinary Extracellular Vesicles for Colorectal Cancer: Comparison of DNA Quality and MRD Detection. Cancer Science. https://doi.org/10.1111/cas.70368
Vancouver
Kanaka S, Yamada T, Asai F, Shimizu Y, Uehara K, Matsuda A, et al. Utility of Urinary Extracellular Vesicles for Colorectal Cancer: Comparison of DNA Quality and MRD Detection. Cancer Science. 2026. doi:10.1111/cas.70368
BibTeX
@article{Kanaka2026,
author = {Kanaka, Shintaro and Yamada, Takeshi and Asai, Fumi and Shimizu, Yuta and Uehara, Kay and Matsuda, Akihisa and Shinji, Seiichi and Yokoyama, Yasuyuki and Takahashi, Goro and Iwai, Takuma and Takeda, Kohki and Kuriyama, Sho and Miyasaka, Toshimitsu and Hayashi, Koki and Yoshida, Hiroshi},
title = {Utility of Urinary Extracellular Vesicles for Colorectal Cancer: Comparison of DNA Quality and MRD Detection},
journal = {Cancer Science},
year = {2026},
doi = {10.1111/cas.70368}
}
EUVIMED